Kelsey McLaughlin
Overview
Explore the profile of Kelsey McLaughlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gladstone R, Ahmed S, Huszti E, McLaughlin K, Snelgrove J, Taher J, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2444454.
PMID: 39541121
Importance: Early preterm birth (ie, at less than 34 weeks' gestation) confers a high risk for adverse health outcomes, yet no universal screening strategy exists, preventing targeted delivery of effective...
2.
Malhame I, Nerenberg K, McLaughlin K, Grandi S, Daskalopoulou S, Metcalfe A
JAMA Netw Open
. 2024 Oct;
7(10):e2436478.
PMID: 39361284
Importance: The incidence of severe maternal morbidity (SMM)-and particularly cardiovascular SMM (cvSMM), the first cause of pregnancy-related mortality-has been rising in North America. Although hypertensive disorders of pregnancy (HDP) are...
3.
Snelgrove J, Lee R, Jeyakumar Y, Greenblatt E, Kingdom J, Zwingerman R, et al.
J Assist Reprod Genet
. 2024 Jul;
41(10):2721-2726.
PMID: 39042339
Purpose: In vitro fertilization (IVF) is associated with abnormal trophoblast invasion and resultant decreased levels of circulating placental biomarkers such as placental growth factor (PlGF). Our objective was to evaluate...
4.
Zur R, McLaughlin K, Aalto L, Jiang Y, Huszti E, Parks W, et al.
BJOG
. 2024 May;
131(11):1515-1523.
PMID: 38725333
Objective: To identify which components of maternal vascular malperfusion (MVM) pathology are associated with adverse pregnancy outcomes and to investigate the morphological phenotypes of MVM placental pathology and their relationship...
5.
McLaughlin K, Snelgrove J, Sienas L, Easterling T, Kingdom J, Albright C
J Am Heart Assoc
. 2022 Mar;
11(7):e023694.
PMID: 35285667
Hypertensive disorders of pregnancy are among the most serious conditions that pregnancy care providers face; however, little attention has been paid to the concept of tailoring clinical care to reduce...
6.
McLaughlin K, Hobson S, Ravi Chandran A, Agrawal S, Windrim R, Parks W, et al.
Am J Obstet Gynecol
. 2021 Aug;
226(2S):S1145-S1156.e1.
PMID: 34461078
Background: Patients at high risk of severe preeclampsia and fetal growth restriction have low circulating levels of placental growth factor and features of maternal vascular malperfusion placental pathology at delivery....
7.
McLaughlin K, Snelgrove J, Audette M, Syed A, Hobson S, Windrim R, et al.
Hypertension
. 2021 Apr;
77(6):2057-2065.
PMID: 33840202
[Figure: see text].
8.
Audette M, McLaughlin K, Kingdom J
J Obstet Gynaecol Can
. 2021 Feb;
43(10):1145-1152.e1.
PMID: 33621677
Objective: Placental growth factor (PlGF) levels are lower at delivery in pregnancies with preeclampsia or fetuses small for gestational age (SGA). These obstetrical complications are typically mediated by placental dysfunction,...
9.
Doherty A, McLaughlin K, Kingdom J
Clin Perinatol
. 2020 Jul;
47(3):653-670.
PMID: 32713456
Normal pregnancy is a complex and dynamic process that requires significant adaptation from the maternal system. Failure of this adaptive process in pregnancy contributes to many pregnancy related disorders, including...
10.
McLaughlin K, Nadeem L, Wat J, Baczyk D, Lye S, Kingdom J
Am J Physiol Heart Circ Physiol
. 2020 Mar;
318(4):H1008-H1017.
PMID: 32196359
Circulating levels of placental growth factor (PlGF) are significantly reduced in women who develop preeclampsia. Low molecular weight heparin (LMWH) has been shown to acutely elevate circulating PlGF levels in...